QoL from TASCO1: Health-related quality of life of trifluridine/tipiracil-bevacizumab and capecitabine-bevacizumab as first-line treatments in metastatic colorectal cancer patients not eligible for intensive chemotherapy-Results from the TASCO1 phase II s

Affiliation auteurs!!!! Error affiliation !!!!
TitreQoL from TASCO1: Health-related quality of life of trifluridine/tipiracil-bevacizumab and capecitabine-bevacizumab as first-line treatments in metastatic colorectal cancer patients not eligible for intensive chemotherapy-Results from the TASCO1 phase II s
Type de publicationJournal Article
Year of Publication2019
AuteursMoiseyenko V, Saunders MP, Wasan HSingh, Argiles G, Borg C, Creemers G-J, Fedyanin M, Glynne-Jones R, Pfeiffer P, Punt CJA, Stroyakovskiy D, Tije AJTen, Van de Wouw AW, Kanehisa A, Fougeray R, Sabater J, Amellal N, Van Cutsem E
JournalJOURNAL OF CLINICAL ONCOLOGY
Volume37
Date PublishedFEB 1
Type of ArticleMeeting Abstract
ISSN0732-183X
DOI10.1200/JCO.2019.37.4_suppl.676